Literature DB >> 19095562

Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias.

Albert K Ho1, Sally Hill, Sergey N Preobrazhensky, Mark E Miller, Zhong Chen, David W Bahler.   

Abstract

Mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) are CD5+ small B-cell neoplasms (SBCNs) with overlapping features. Flow cytometric immunophenotyping is often used to help differentiate CLL from MCL, and a characteristic CLL phenotype is considered essentially diagnostic. However, previous studies have not specifically examined how well a typical MCL immunophenotype distinguishes MCL from CLL. We identified 28 cases of SBCN with typical flow cytometry-determined MCL immunophenotypes consisting mostly of peripheral blood and bone marrow specimens. Fluorescence in situ hybridization analysis indicated that 57% (16/28) had t(11;14) translocations consistent with MCL, while 32% (9/28) lacked t(11;14) translocations but harbored other cytogenetic abnormalities commonly found in CLL. There were no significant morphologic or immunophenotypic differences between the t(11;14)-positive and t(11;14)-negative cases. Our findings suggest that many blood-based SBCNs with typical MCL immunophenotypes likely represent cases of phenotypically atypical CLL, which would have important clinical implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19095562     DOI: 10.1309/AJCPPAG4VR4IPGHZ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.

Authors:  Daisy Alapat; Jean Coviello-Malle; Rebecca Owens; Pingping Qu; Bart Barlogie; John D Shaughnessy; Robert B Lorsbach
Journal:  Am J Clin Pathol       Date:  2012-01       Impact factor: 2.493

2.  Clinical laboratory analysis of immunoglobulin heavy chain variable region genes for chronic lymphocytic leukemia prognosis.

Authors:  Philippe Szankasi; David W Bahler
Journal:  J Mol Diagn       Date:  2010-01-28       Impact factor: 5.568

3.  An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.

Authors:  Mauricio Zapata; Steven D Budnick; Rodolfo Bordoni; Shiyong Li
Journal:  Int J Clin Exp Pathol       Date:  2010-03-20

4.  A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report.

Authors:  Cristiano Krings Rocha; Inka Praulich; Iris Gehrke; Michael Hallek; Karl-Anton Kreuzer
Journal:  Mol Cytogenet       Date:  2011-04-01       Impact factor: 2.009

5.  Recent advances in bone marrow biopsy pathology.

Authors:  Jon van der Walt
Journal:  J Hematop       Date:  2009-05-14       Impact factor: 0.196

6.  Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation.

Authors:  Yvonne Kiefer; Christoph Schulte; Markus Tiemann; Joern Bullerdiek
Journal:  Appl Clin Genet       Date:  2012-03-12

7.  Rituximab-Induced Splenic Rupture and Cytokine Release.

Authors:  Ranjit Nair; Shereen Gheith; Nicholas Lamparella
Journal:  Am J Case Rep       Date:  2016-03-14

8.  Efficacy and Safety of Ibrutinib in Indian Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma: Cases from a Named Patient Program.

Authors:  Mohan B Agarwal; Dinesh Bhurani; Chirag Shah; Nitin Sood; Manish Singhal; Anil Kamat; Subash Chezhian; Suryaprakash Mishra; Dinesh Nagrale
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.